Story perspectives

Revolutionary Antibiotic Gepotidacin Targets Resistant UTIs

3/1/2025

50 11

Summary

Story summary

In an insightful interview, Dr. Marilyn N. Bulloch unveiled gepotidacin, a groundbreaking oral antibiotic poised to combat urinary tract infections. This innovative drug uniquely targets fluoroquinolone-resistant pathogens, marking a significant leap in antibiotic development in two decades. With fewer gastrointestinal side effects and a safer profile for patients battling multi-drug-resistant bacteria, gepotidacin could transform treatment options.

1 of 1

Story summary

In an insightful interview, Dr. Marilyn N. Bulloch unveiled gepotidacin, a groundbreaking oral antibiotic poised to combat urinary tract infections. This innovative drug uniquely targets fluoroquinolone-resistant pathogens, marking a significant leap in antibiotic development in two decades. With fewer gastrointestinal side effects and a safer profile for patients battling multi-drug-resistant bacteria, gepotidacin could transform treatment options.